The antitumour effect of the somatostatin analogue TT-232 depends on the treatment regimen.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/82FFC0F8.svg?ark=w1%2F20260515%2F82FFC0F8)](https://nobleid.org/work/w1/20260515/82FFC0F8)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors